RT Journal Article
SR Electronic
T1 Detection of SARS-CoV-2 in Exhaled Breath from COVID-19 Patients Ready for Hospital Discharge
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.31.20115196
DO 10.1101/2020.05.31.20115196
A1 Zhou, Lian
A1 Yao, Maosheng
A1 Zhang, Xiang
A1 Hu, Bicheng
A1 Li, Xinyue
A1 Chen, Haoxuan
A1 Zhang, Lu
A1 Liu, Yun
A1 Du, Meng
A1 Sun, Bochao
A1 Jiang, Yunyu
A1 Zhou, Kai
A1 Hong, Jie
A1 Yu, Na
A1 Ding, Zhen
A1 Xu, Yan
A1 Hu, Min
A1 Morawska, Lidia
A1 Grinshpun, Sergey A.
A1 Biswas, Pratim
A1 Flagan, Richard C.
A1 Zhu, Baoli
A1 Liu, Wenqing
A1 Zhang, Yuanhang
YR 2020
UL http://medrxiv.org/content/early/2020/06/02/2020.05.31.20115196.abstract
AB The COVID-19 pandemic has brought an unprecedented crisis to the global health sector1. When recovering COVID-19 patients are discharged in accordance with throat or nasal swab protocols using reverse transcription polymerase chain reaction (RT-PCR), the potential risk of re-introducing the infection source to humans and the environment must be resolved2,3,4. Here we show that 20% of COVID-19 patients, who were ready for a hospital discharge based on current guidelines, had SARS-CoV-2 in their exhaled breath (∼105 RNA copies/m3). They were estimated to emit about 1400 RNA copies into the air per minute. Although fewer surface swabs (1.3%, N=318) tested positive, medical equipment frequently contacted by healthcare workers and the work shift floor were contaminated by SARS-CoV-2 in four hospitals in Wuhan. All air samples (N=44) appeared negative likely due to the dilution or inactivation through natural ventilation (1.6–3.3 m/s) and applied disinfection. Despite the low risk of cross environmental contamination in the studied hospitals, there is a critical need for strengthening the hospital discharge standards in preventing re-emergence of COVID-19 spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the National Natural Science Foundation of China grant (22040101), the Chinese Academy of Engineering Grant (2020-ZD-15 ) dedicated to the COVID-19 pandemic. This work was also partially supported by the NSFC Distinguished Young Scholars Fund Awarded to M. Yao (21725701), and Scientific Research Fund of Jiangsu Provincial Health Committee(S2017002).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The recruitment was conducted during the period of 26 Feb -25 March, 2020; and the ethics involving patients' exhaled breath non-invasive collection was approved and waived due to the emergence matter by the ethics committee of Jiangsu Provincial Center for Disease Prevention and Control.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are included in the manuscript and supporting information files.